Real-world use of once-weekly semaglutide in patients with type 2 diabetes: Results from the SURE Switzerland multicentre, prospective, observational study

Autor:	Rudofsky, Gottfried, Catarig, Andrei-Mircea, Favre, Lucie, Grau, Katrine, Häfliger, Susan, Thomann, Robert, Schultes, Bernd
Zdroj:	In Diabetes Research and Clinical Practice August 2021 178
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect